Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Amato

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Obstetrics and Gynecology|June 12, 2003
Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cyclesGiovanni Amato, Marisa Conte, Gherardo Mazziotti, et al.
Clinical Endocrinology|October 2, 2002
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized studyCarlo Carella, Gherardo Mazziotti, Mario Rotondi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinomaGherardo Mazziotti, Francesca Sorvillo, Marco Piscopo, et al.
European Journal of Endocrinology|March 27, 2003
Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditisGherardo Mazziotti, Francesca Sorvillo, Caterina Naclerio, et al.
Clinical Endocrinology|July 17, 2003
Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto's thyroiditisGherardo Mazziotti, Francesca Sorvillo, Sergio Iorio, et al.
Clinical Endocrinology|July 26, 2011
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinomaRoberto Nersita, Antonio Matrone, Michele Klain, et al.
Clinical Endocrinology|February 19, 2002
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegalyGiovanni Amato, Gherardo Mazziotti, Mario Rotondi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Recombinant human thyrotropin reduces serum vascular endothelial growth factor levels in patients monitored for thyroid carcinoma even in the absence of thyroid tissueFrancesca Sorvillo, Gherardo Mazziotti, Antonella Carbone, et al.
Biomedicines|May 28, 2022
Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's DiseaseTeresa Musumeci, Giulia Di Benedetto, Claudia Carbone, et al.
Clinical Endocrinology|February 13, 2003
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosisFrancesca Sorvillo, Gherardo Mazziotti, Antonella Carbone, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Obstetrics and Gynecology|June 12, 2003
Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cyclesGiovanni Amato, Marisa Conte, Gherardo Mazziotti, et al.
Clinical Endocrinology|October 2, 2002
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized studyCarlo Carella, Gherardo Mazziotti, Mario Rotondi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2005
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinomaGherardo Mazziotti, Francesca Sorvillo, Marco Piscopo, et al.
European Journal of Endocrinology|March 27, 2003
Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditisGherardo Mazziotti, Francesca Sorvillo, Caterina Naclerio, et al.
Clinical Endocrinology|July 17, 2003
Grey-scale analysis allows a quantitative evaluation of thyroid echogenicity in the patients with Hashimoto's thyroiditisGherardo Mazziotti, Francesca Sorvillo, Sergio Iorio, et al.
Clinical Endocrinology|July 26, 2011
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinomaRoberto Nersita, Antonio Matrone, Michele Klain, et al.
Clinical Endocrinology|February 19, 2002
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegalyGiovanni Amato, Gherardo Mazziotti, Mario Rotondi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Recombinant human thyrotropin reduces serum vascular endothelial growth factor levels in patients monitored for thyroid carcinoma even in the absence of thyroid tissueFrancesca Sorvillo, Gherardo Mazziotti, Antonella Carbone, et al.
Biomedicines|May 28, 2022
Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's DiseaseTeresa Musumeci, Giulia Di Benedetto, Claudia Carbone, et al.
Clinical Endocrinology|February 13, 2003
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosisFrancesca Sorvillo, Gherardo Mazziotti, Antonella Carbone, et al.
Pageof 4